Neu5Ac alpha(2-6)Gal beta MP glycoside(1984814-41-6)
- Name: Neu5Ac alpha(2-6)Gal beta MP glycoside
- Synonyms:4-Methoxyphenyl 6-O-(N-Acetyl-alpha-neuraminosyl)-beta-D-galactopyranoside 4-Methoxyphenyl O-(5-Acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosylonic Acid)-(2-6)-beta-D-galactopyranoside;β-D-Galactopyranoside, 4-methoxyphenyl 6-O-(N-acetyl-α-neuraminosyl)-;4-Methoxyphenyl O-(5-Acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosonic Acid)-(2-6)-beta-D-galactopyranoside;Neu5Ac alpha(2-6)Gal-beta-MP;Neu5Acα(2-6)Galβ MP Glycoside;Neu5Ac alpha(2-6)Gal beta MP glycoside
- Molecular Formula:C24H35NO15
- Molecular Weight:577.54
- CAS Registry Number:1984814-41-6
- EINECS:
- Melting Point:985.5±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 1984184-02-2/azepane-4-carbonitrile hydrochloride
- 19842-14-9/3-ethyl-1,4-dihydropyridin-4-imine hydrochloride
- 198422-74-1/2-(3-bromopropoxy)acetic acid
- 198422-78-5/3H-Indolium,1-(5-carboxypentyl
- 19843-12-0/16H-1,25:6,9-Dietheno-11,15:20,23-dimetheno-2H,15H-[1,11]dioxacyclodocosino[5,4-b:18,19-b']dipyridine, 3,5,18,19-tetrahydro-12,21,22,27-tetramethoxy- (8CI,9CI)
- 1984-55-0/2,2'-THENIL, 98%
- 198470-02-9/Boc-L-ChgDCHA
- 198470-91-6/Parecoxib ImpurityO
- 198470-92-7/Parecoxib SodiuM iMpurity D
- 198471-47-5/N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl) sulfonyl)acetamide
- 198473-91-5/Bicyclo[2.2.1]hept-2-en-7-ol, 7-ethynyl-, anti- (9CI)
- 198473-95-9/Boc-homotyr-OH dcha
- 198474-91-8/Boc-3,4-difluoro-L-Phe-OH dcha
- 198475-65-9/L-Phenylalanine, 4-[[[(2-chlorophenyl)methoxy]carbonyl]amino]-N-[(1,1-dimethylethoxy)carbonyl]-
- 1984776-37-5/Azido-PEG9-alcohol
- 1984776-38-6/Azido-PEG7-CH2COOtBu
- 1984776-39-7/N3-PEG8-CH2COOtBu
- 1984780-08-6/9-Octadecenoic acid (9Z)-, 2-[[2-[(carboxymethyl)thio]acetyl]oxy]ethyl ester
- 198478-36-3/N-α-Benzoyl-L-methioninamide
- 1984814-41-6/Neu5Ac alpha(2-6)Gal beta MP glycoside
- 1984814-42-7/Galβ(1-3)[Neu5Acα(2-6)]GalNAc-β-pNP
- 1984824-54-5/2-Pyrrolidinecarboxamide, 4-fluoro-1-[(4-fluorophenyl)sulfonyl]-5-methyl-N-[[5-(trifluoromethyl)-2-[2-(trifluoromethyl)-5-pyrimidinyl]-4-pyridinyl]methyl]-, (2S,4R,5S)-
- 1984825-08-2/TRPA1 Antagonist 1
- 1984825-18-4/(2S,4S,5S)-1-tert-butyl 2-methyl 4-hydroxy-5-methylpyrrolidine-1,2-dicarboxylate(WXC02497)
- 1984825-19-5/O1-tert-butyl O2-methyl (2S,4R,5S)-4-fluoro-5-methyl-pyrrolidine-1,2-dicarboxylate
- 1984825-20-8/1,2-Pyrrolidinedicarboxylic acid, 4-fluoro-5-methyl-, 1-(1,1-dimethylethyl) ester, (2S,4R,5S)-
- 1984825-25-3/(S)-4-(tert-Butoxycarbonyl)-4-azaspiro[2.4]heptane-5-carboxylic acid
- 1984825-82-2/1,2-Pyrrolidinedicarboxylic acid, 4-hydroxy-5-methyl-, 1-(1,1-dimethylethyl) ester, (2S,4S,5S)-
- 1984826-57-4/3-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine
- 1984827-20-4/2-Trifluoromethyl-3-ethoxycarbonyl-pyridine-5-boronic acid